FDA Approved: ABIRATERONE ACETATE — Supplemental Application (NORTHSTAR RX LLC)

View source ↗

Summary

FDA approved a supplemental application for Abiraterone acetate from Northstar RX LLC, resulting in approval of a generic product under ANDA 209227.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)